ASK1/p38 axis inhibition blocks the release of mitochondrial “danger signals” from hepatocytes and suppresses progression to cirrhosis and liver cancer

肝硬化 细胞凋亡 肝细胞 线粒体 医学 肝癌 纤维化 内科学 癌症研究 化学 癌症 细胞生物学 体外 生物 生物化学
作者
Zhenwei Peng,Guangyan Wei,Pinzhu Huang,Heansika Matta,Wen Gao,Ping An,Shuangshuang Zhao,Yi Lin,Li Tan,Kahini A. Vaid,Disha Skelton-Badlani,Imad Nasser,Grant R. Budas,David López,Li Li,David G. Breckenridge,Rob Myers,John G. McHutchison,Ming Kuang,Yury Popov
出处
期刊:Hepatology [Lippincott Williams & Wilkins]
卷期号:80 (2): 346-362 被引量:12
标识
DOI:10.1097/hep.0000000000000801
摘要

BACKGROUND AND AIMS: Apoptosis Signal-regulating Kinase 1 (ASK1) is activated by various pathological stimuli and induces cell apoptosis through downstream p38 activation. We studied the effect of pharmacological ASK1 inhibition on cirrhosis and its sequelae using comprehensive preclinical in vivo and in vitro systems. APPROACH AND RESULTS: Short-term (4-6 wk) and long-term (24-44 wk) ASK1 inhibition using small molecule GS-444217 was tested in thioacetamide-induced and BALB/c. Mdr2-/- murine models of cirrhosis and HCC, and in vitro using primary hepatocyte cell death assays. Short-term GS-444217 therapy in both models strongly reduced phosphorylated p38, hepatocyte death, and fibrosis by up to 50%. Profibrogenic release of mitochondrial DAMP mitochondrial deoxyribonucleic acid from dying hepatocytes was blocked by ASK1 or p38 inhibition. Long-term (24 wk) therapy in BALBc.Mdr2 - / - model resulted in a moderate 25% reduction in bridging fibrosis, but not in net collagen deposition. Despite this, the development of cirrhosis was effectively prevented, with strongly reduced p21 + hepatocyte staining (by 72%), serum ammonia levels (by 46%), and portal pressure (average 6.07 vs. 8.53 mm Hg in controls). Extended ASK1 inhibition for 44 wk in aged BALB/c. Mdr2-/- mice resulted in markedly reduced tumor number and size by ~50% compared to the control group. CONCLUSIONS: ASK1 inhibition suppresses the profibrogenic release of mitochondrial deoxyribonucleic acid from dying hepatocytes in a p38-dependent manner and protects from liver fibrosis. Long-term ASK1 targeting resulted in diminished net antifibrotic effect, but the progression to liver cirrhosis and cancer in BALBc/ Mdr2- / - mice was effectively inhibited. These data support the clinical evaluation of ASK1 inhibitors in fibrotic liver diseases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
海伦发布了新的文献求助10
刚刚
1秒前
2秒前
lyn发布了新的文献求助20
3秒前
gch发布了新的文献求助10
3秒前
yuntaoZ完成签到,获得积分10
3秒前
Conqurd发布了新的文献求助10
4秒前
还等雨落的应助被xc采纳,获得10
4秒前
5秒前
wqjfduy发布了新的文献求助10
5秒前
CipherSage的应助被进取拼搏采纳,获得10
5秒前
5秒前
6秒前
Angla1114完成签到,获得积分10
6秒前
6秒前
6秒前
科研通AI6.4的应助被大橙子采纳,获得10
7秒前
英姑的应助被qianye采纳,获得10
8秒前
nini完成签到,获得积分10
8秒前
英姑的应助被闪耀的启明星采纳,获得10
9秒前
9秒前
10秒前
彭于晏的应助被SUN采纳,获得10
11秒前
许译匀发布了新的文献求助10
11秒前
传奇3的应助被tanglu采纳,获得10
11秒前
小蘑菇的应助被Conqurd采纳,获得10
12秒前
iceicefdtd发布了新的文献求助10
12秒前
yk发布了新的文献求助10
13秒前
俏皮的寄风完成签到,获得积分10
14秒前
15秒前
wanling完成签到,获得积分10
16秒前
Jun的应助被胡萝卜卜采纳,获得10
16秒前
16秒前
爆米花的应助被小拉卡咪采纳,获得10
17秒前
Brian发布了新的文献求助10
17秒前
17秒前
qianye完成签到,获得积分20
18秒前
18秒前
18秒前
ding的应助被莉莉丝采纳,获得10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194174
求助须知:如何正确求助?哪些是违规求助? 9580103
关于积分的说明 21869209
捐赠科研通 7793764
什么是DOI,文献DOI怎么找? 3437545
关于科研通互助平台的介绍 2560983
邀请新用户注册赠送积分活动 2484291